Related by context. All words. (Click for frequent words.) 70 alpha folate receptor 70 investigational humanized monoclonal antibody 69 oral kinase inhibitor 68 investigational immunotherapy 68 prostate cancer antigen prostatic 67 chemically modified siRNA 67 targeted antifolate 67 Pralatrexate 67 M2 subunit 67 multi kinase inhibitor 67 antibody fragment 67 c Raf kinase 67 CD4 monoclonal antibody 67 siRNA therapeutic 67 proteasome inhibitor 66 monoclonal antibody mAb 66 accumulate preferentially 66 CCX# 66 A3 adenosine receptor 66 humanized monoclonal antibody 66 selective kinase inhibitor 66 HCV protease 65 ENMD # 65 NEUGENE antisense compound 65 humanized antibody 65 specific lectin receptors 65 soluble receptor 65 XmAb# 65 mertansine 65 antisense oligonucleotide 65 orally bioavailable 64 CYC# 64 Locked Nucleic Acid LNA 64 ribonucleotide reductase clinically validated 64 chimeric monoclonal antibody 64 Elotuzumab 64 MT#/MEDI-# 64 IgG1 monoclonal antibody 64 Blinatumomab 64 drug conjugate 64 Angiocept 64 IgG1 antibody 63 Protein Kinase C 63 Pertuzumab 63 Xencor XmAb 63 Angiolix 63 Anticalin R 63 mTOR inhibitor 63 oral prodrug 63 liposomal formulation 63 tyrosine kinase receptor 63 Payload TAP technology 63 EGFR pathway 63 ketolide antibiotic 63 IMA# 63 Aflibercept 63 erlotinib Tarceva ® 63 VitiGam 63 protein kinase inhibitor 63 XL# inhibits 63 IAP inhibitor 63 selective agonist 63 PNP inhibitor 63 histone deacetylase HDAC inhibitor 63 pertuzumab 63 Rigel R# 63 Epidermal Growth Factor Receptor 62 Tumor Necrosis Factor 62 targeting CD# 62 PKC# 62 Aurora kinase 62 anti angiogenic agent 62 BiTE ® 62 PEGylated Fab fragment 62 histone deacetylase HDAC 62 HER1 62 Bavituximab 62 Sphingomab 62 VEGF receptor 62 virus AAV 62 systemic RNAi therapeutic 62 T#I [002] 62 CD# monoclonal antibody 62 enzyme inhibitor 62 chemokine receptor 62 VeraTag 62 OncoVEX 62 Enzastaurin 62 kinase inhibitor 62 PI3K/mTOR 62 humanized monoclonal 62 pan HDAC inhibitor 62 targeted radiotherapeutic 62 intratumoral injection 62 Fc fusion protein 62 Anticalins R 62 hormone gastrin 62 sodium glucose cotransporter 62 MAGE A3 ASCI 62 antisense inhibitor 62 taxane derivative 62 selectively inhibit 61 orthotopic model 61 immunomodulator 61 immune stimulatory 61 receptor tyrosine kinase inhibitor 61 investigational monoclonal antibody 61 humanized anti 61 secretory phospholipase A2 61 IMC #B 61 tyrosine kinase inhibitor 61 Chemokine Receptor 61 DiLA2 61 Deforolimus 61 DG# compounds targeting 61 selective antagonist 61 angiogenesis inhibitor 61 humanized monoclonal antibodies 61 molecularly targeted 61 FGFR 61 Transdrug ® nanoparticle 61 immunotherapeutic 61 potent topoisomerase II 61 HSP# inhibitor 61 product Pixel Precision 61 recombinant adeno associated 61 HCV protease inhibitor 61 immunostimulatory 61 Xanafide 61 ATL# [001] 61 PI3K inhibitors 61 stable nucleic acid 61 recombinant subunit vaccine 61 novel peptide 61 CXCR4 receptor 61 BiTE R 61 VEGFR2 61 imatinib Gleevec 61 OncoVex 61 Traficet EN 61 imatinib Gleevec ® 61 MET amplification 61 ALK inhibitor 61 angina nausea 61 peptide antigens 61 anticancer compound 61 CCR2 receptor 61 PDE4 inhibitor 61 cleavable linker 61 bispecific 61 potent inhibitor 61 Carfilzomib 61 Omacetaxine 61 anti CD3 61 NS#/#A protease 60 bispecific antibodies 60 MAbs targeting 60 HuLuc# 60 sPLA2 60 Liposomal 60 ZFP TF 60 MMAE 60 JAK1 60 Alfacell proprietary ribonuclease 60 peptidomimetic 60 cytotoxin 60 PRT# 60 anti EGFR antibody 60 inhibit EGFR 60 fosbretabulin 60 OncoVEX GM CSF 60 Panzem R 60 small molecule agonists 60 Nanobody 60 IMiDs R 60 PLX MS 60 Aptamer 60 Factor Receptor 60 AEG# 60 SAR# [002] 60 monoclonal antibody 60 Olaparib 60 selective orally bioavailable 60 RNAi therapeutic targeting 60 monoclonal antibodies mAbs 60 investigational therapies 60 CD# molecule 60 bispecific antibody 60 PI3K inhibitor 60 Proxinium TM 60 Intravenous Human 60 antitumor 60 ADP receptor antagonist 60 #T# tumor 60 CEA CD# Her2 60 chemotherapeutic agent 60 M2e 60 cytolytic 60 Anticalin ® 60 agonistic human 60 RAF kinase 60 including HGF ErbB3 60 c MET 60 Epratuzumab 60 HCV polymerase 60 BRAF inhibitor 60 CD# antibodies 60 chemotherapeutic drug 60 oncolytic 60 Homspera TM 60 attach auristatin 60 factor Xa 60 PARP inhibitor 60 SAR# [004] 60 depsipeptide 60 potent antiproliferative 60 CBLC# 60 co stimulatory molecules 60 engineered RAP peptides 60 Degarelix 60 potent cytotoxic 60 candidate Lovaxin C 60 antibody MAb 60 antagomirs 60 poly ADP ribose polymerase 60 fusion inhibitor 60 antigen CD# 60 humanised monoclonal antibody 60 small molecule defensin 60 lexidronam injection 60 somatostatin analogue 60 human monoclonal antibody 60 NPC 1C 60 Trastuzumab 60 neuronal nicotinic receptor NNR 60 immunotoxin 60 Anticalins ® 60 Factor VIIa 60 Telatinib 60 chimeric protein 60 monoclonal antibody MAb 59 RAS MAPK pathway 59 CDDO Im 59 IMC A# 59 autologous cellular immunotherapy 59 TTR gene 59 HQK 59 Dasatinib 59 luteinizing hormone releasing 59 histone deacetylase inhibitors 59 anticancer agent 59 alkylating agent 59 antisense drug 59 lipid nanoparticle 59 siRNA delivery 59 miRview mets 59 ALN TTR 59 Tumour VDA 59 TPI ASM8 59 BiTE 59 C5aR 59 vinca alkaloid 59 soluble tumor necrosis 59 Tarvacin 59 Genentech Rituxan 59 demonstrated anti amnesic 59 rapamycin mTOR 59 CDK inhibitor 59 Nanobody ® 59 ESBA# 59 Immunohistochemical analysis 59 protein tyrosine phosphatase 1B 59 huC# DM4 59 humanised antibody 59 Sphingomab TM 59 tubulin inhibitor 59 BCR ABL 59 GRNVAC1 59 potent inhibitory 59 DF #D missile 59 IGF IR 59 Anthrax Toxin 59 orally dosed 59 PTH analogue 59 antisense oligonucleotides 59 delta isoform 59 Elvitegravir 59 bortezomib Velcade ® 59 Preclinical studies suggest 59 opioid receptor antagonist 59 Micromet BiTE 59 5 HT4 receptor 59 TLR9 agonist 59 anti CD# monoclonal 59 Micromet proprietary BiTE 59 novel topoisomerase 59 immune modulatory 59 Antigenics QS 59 FK# 59 neuraminidase inhibitor 59 histone deacetylase inhibitor 59 mda 7 59 Gleevec resistant 59 delipidation 59 HDACi 59 orally administered inhibitor 59 B lymphocyte stimulator 59 Guanilib 59 nucleoside analog 59 immunoconjugate 59 rxRNA 59 Erlotinib 59 histone deacetylase 59 Aurora kinase inhibitor 59 Gefitinib 59 therapeutic monoclonal antibody 59 inhibit VEGF 59 cMET 59 Pentraxin 2 59 JAK inhibitors 59 Sym# 59 Medarex UltiMAb R 59 chemotherapy induced neutropenia 59 HCD# [002] 59 MEK inhibitor 59 CCR9 59 EGF receptor 59 epithelial tumors 59 cetuximab Erbitux ® 59 THR beta agonist 59 peripherally acting 59 rHuPH# recombinant human 59 selective inhibitor 59 vascular disrupting agent 58 BRAF inhibitors 58 adenovector 58 Cobalamin TM mediated 58 myelofibrosis polycythemia vera 58 BiTE antibody 58 Aptocine 58 peptibody 58 gamma secretase inhibitors 58 interleukin IL -# 58 Stapled Peptide 58 exon skipping 58 selective modulator 58 anti CD3 monoclonal 58 eTag assays 58 Scancell 58 novel immunomodulatory 58 cytostatic 58 Valortim 58 adjuvant GIST 58 ganetespib 58 ocular formulation 58 TRX1 58 HuMax CD# 58 engineered proteases 58 Zolinza 58 protective antigen 58 deacetylase 58 OMP #M# 58 extracellular domain 58 adenoviral 58 VitiGam TM 58 HTS assay 58 anti amnesic 58 cytoprotective 58 ErbB3 58 fusion proteins 58 telomerase reverse transcriptase 58 Temsirolimus 58 PSMA ADC 58 prophylactic vaccine 58 ESPRIT therapy 58 sphingosine 1 58 selective inverse agonist 58 Maribavir 58 fluoropyrimidine 58 oncolytic viruses 58 Vaxfectin 58 oncolytic virus therapies 58 short interfering RNA 58 murine monoclonal antibody 58 antibody MT# 58 mu opioid receptor antagonist 58 RNAi therapeutic 58 paclitaxel Taxol 58 Panitumumab 58 gastrointestinal stromal tumors GISTs 58 alpha#beta# integrin 58 small molecule glucokinase 58 vitro assay 58 synthetic peptide 58 Monoclonal Antibody 58 Multimeric 58 Personalized Immunotherapy 58 selective adenosine 58 small molecule tyrosine 58 insomnia migraine headaches 58 MUC1 58 selective inhibition 58 AT1R 58 recombinant fusion 58 humanized antibodies 58 CCR9 antagonist 58 liposomal doxorubicin 58 herpes simplex viruses 58 recombinant antibodies 58 immune modulating 58 BAY #-# 58 IgG1 58 inhibit viral replication 58 prostacyclin receptor 58 serine protease 58 metaglidasen 58 Onalta 58 LymphoStat B belimumab 58 PEGylated 58 chimeric antibodies 58 POTELLIGENT ® 58 signal transduction inhibitor 58 CTLA 4 58 Kahalalide F 58 modulate ion channel 58 MKC# MT 58 Preclinical Study 58 Ceflatonin 58 radiolabeled monoclonal antibody 58 Vicinium TM 58 Onconase 58 INS# [001] 58 effector function 58 MAb 58 IRX 2 58 antisense inhibitors 58 antitumoral 58 avidin 58 HGS ETR1 58 endosomal release 58 PEG SN# 58 CD# antibody [001] 58 FLT3 58 PI3K/Akt pathway inhibitor 58 thrombopoietin 58 hypoxia inducible factor 58 tubulin binding 58 AGS PSCA 58 humanised antibody designed 58 CEQ# 58 virosome 58 Azedra 58 intranasal formulation 58 AtuRNAi 57 Flt3 57 HER3 57 elotuzumab 57 miRview TM mets 57 siRNA compounds 57 BAL# [001] 57 metastatic colorectal 57 potently inhibit 57 RiVax 57 Talabostat 57 azoles 57 JAK2 inhibitor 57 antiproliferative effects 57 Lenalidomide 57 polymerase inhibitor 57 SERMs 57 HuMax CD4 57 UsiRNAs 57 pretargeting 57 Oral NKTR 57 therapeutic monoclonal antibodies 57 KinomeScan 57 flu mAb 57 Tarvacin TM 57 colorectal bladder 57 molecular biomarkers 57 proteasome inhibitors 57 favorable pharmacokinetic profile 57 tumor specific antigen 57 Boceprevir 57 HepDirect prodrug 57 NFkB 57 mTOR mammalian target 57 Cytotoxic T 57 HER2/neu 57 HIF PH inhibitors 57 small molecule inhibitor 57 non nucleoside 57 Bezielle 57 polyclonal antibody 57 dacetuzumab 57 neutralizing antibody 57 Vorinostat 57 MetaDrug TM 57 GRN#L 57 PORxin TM 57 oncolytic virus 57 florbetaben 57 TLR7 57 induces antibodies 57 HGS ETR2 57 CD3 monoclonal antibody 57 Fibroblast Growth Factor Receptor 57 AKT inhibitor 57 Prodarsan ® 57 thrombin receptor 57 Bafetinib 57 novel peptides 57 highly immunogenic 57 vascular disrupting agents 57 docetaxel Taxotere R 57 selective androgen receptor modulator 57 bioactive lipids 57 hA# 57 NS4A 57 potently inhibited 57 RAV# 57 CCR2 57 induce apoptosis 57 small molecule inhibitors 57 rhIL 7 57 Dapagliflozin 57 Th# 57 Dalbavancin 57 lysophosphatidic acid LPA 57 Sudhir Agrawal D.Phil 57 AlphaScreen 57 GM CSF granulocyte 57 multiplexed assays 57 rxRNA ™ compounds 57 MVA BN R 57 FBPase 57 Anidulafungin 57 ELISPOT assay 57 intracellular protein 57 EphA2 57 thromboxane A2 57 androgen receptor AR 57 HER2 receptor 57 TNF α 57 preclinically 57 induces apoptosis 57 Enkephalin 57 sclerostin 57 SMaRT ™ 57 tumor antigens 57 TRAIL R2 57 Exelixis compounds 57 LNP formulations 57 vidofludimus 57 K ras mutations 57 HuCAL antibody 57 TG# [003] 57 Vitaxin 57 NEUGENE 57 pips #,# +# pips 57 differentiate squamous 57 HER2 antibody 57 IgG antibodies 57 tiapamil 57 PLX# 57 thymalfasin 57 antifungal agent 57 Chemetics R 57 TRAIL receptor 57 Interferon alpha 57 peroxidase 57 Imprime PGG 57 anti phosphatidylserine 57 Valortim R 57 DFMO 57 Spectrum Selective Kinase 57 syngeneic 57 colon carcinoma 57 erlotinib Tarceva 57 Cyclosert 57 DiLA2 Platform 57 Aptivus ® 57 EGFR HER 57 mRNA mediated 57 bortezomib Velcade 57 LHRH 56 Janus Kinase 56 carbohydrate polymer 56 factor G CSF 56 Luteinizing Hormone Releasing Hormone 56 Western Blotting 56 XL# XL# 56 TLR7 agonist 56 TLR8 agonist 56 HuMax EGFr 56 therapeutic antibody 56 Eg5 56 Litx 56 SIRT2 56 Bortezomib 56 meropenem 56 oral antiviral 56 Hsp# Inhibitor 56 DepoVax TM 56 biomarker identification 56 cell lysis 56 pharmacogenetic test 56 affinity ligands 56 anti CD# antibody 56 massively parallel sequencing 56 Daclizumab 56 Vidofludimus 56 Plasmid DNA 56 tumor antigen 56 EZN 56 brostallicin 56 volociximab 56 protein kinase inhibitors 56 XmAb TM 56 oxidative stress inducer 56 BCR ABL inhibitors 56 #,# +# 56 ImmunoGen TAP technology 56 TBC M4 56 rNAPc2 56 PEGylated interferon 56 SynCon ™ 56 selectively inhibited 56 automated radiopharmaceutical distribution 56 ALN TTR# 56 anticancer therapeutics 56 TRANSDUR ® 56 immunomodulatory 56 GAMMAGARD Liquid ® 56 biotinylated 56 novel histone deacetylase 56 mediate antibody 56 biologic therapeutics 56 bleomycin 56 NeuroVax TM 56 dependent cellular cytotoxicity 56 peptidic compound 56 Anticalin 56 TNFα 56 novel VDA molecule 56 Clusterin 56 intravesical instillation 56 regulate therapeutically important 56 RDEA# potent 56 throughput RNAi 56 CLORETAZINE TM VNP#M 56 MyVax R 56 antibody 56 mammaglobin 56 replicon 56 silico prediction 56 PARP inhibition 56 Leukine ® 56 using Crucell PER.C6 56 duplex siRNA 56 Epothilones 56 inverse agonist 56 reverse vaccinology 56 Oligonucleotide 56 Viprovex TM 56 GV# [001] 56 agonist compounds 56 HGS# 56 nanoviricides 56 plasmid DNA vaccine 56 mAb 56 vorinostat 56 xenograft models 56 amino acid substitution 56 IGF 1R 56 hapten 56 siRNA duplexes 56 Ii protein 56 TLR9 agonists 56 cancer vaccine Norelin 56 EpCAM 56 Ocrelizumab 56 RTP# 56 attenuated strain 56 anticancer therapies 56 silicon carbide SiC gallium 56 PSN# [002] 56 auristatin 56 butyrylcholinesterase 56 P#X# 56 GPNMB 56 aurora kinase inhibitor 56 trastuzumab DM1 T DM1 56 Factor VIIa Factor VIII 56 Rituxan rituximab 56 chemokine 56 HDL Therapy 56 immatics 56 EGFr 56 pharmacodynamic biomarkers 56 serum antibodies 56 peptide conjugated 56 nucleoside reverse transcriptase inhibitor 56 Cardiotoxicity 56 fluoroquinolone antibiotic 56 DHFR 56 apoptotic pathway 56 XOPENEX HFA 56 Bevacizumab 56 receptor monoclonal antibody 56 Ganciclovir 56 JAK3 56 flavopiridol 56 NTDDS 56 GAP #B# 56 hedgehog pathway 56 tkRNAi 56 mapatumumab 56 DepoVax 56 immunohistochemistry IHC 56 SynCon ™ DNA 56 JAK inhibitor 56 Pathway Inhibitor 56 AdVac ® 56 Crofelemer 56 neutralizing antibody responses 56 IL #E 56 retaspimycin 56 MEK inhibitors 56 multigene expression test 56 shRNAs 56 cytotoxic T lymphocyte 56 ISIS Pharmaceuticals 56 TLR antagonist 56 Ofatumumab 56 GeneICE 56 LEX System 56 DNA plasmids 56 monoclonal anti 55 alpha interferon 55 radezolid 55 FAAH 55 Ixempra 55 entinostat 55 Current Lm vaccines 55 highly selective endothelin 55 kinase profiling 55 Syk kinase 55 nicotinic acetylcholine receptor 55 Oragens TM 55 ABL1 55 nCounter Analysis System 55 S/GSK# 55 Tesetaxel 55 telomerase therapeutic 55 microtubule inhibitor 55 NP2 55 E#F# 55 Podtrac survey 55 DermaVir 55 ISF# 55 Pazopanib 55 siRNA knockdown 55 Nexavar ® 55 neurodegenerative diseases Alzheimer disease 55 fusion protein 55 Virulizin ® 55 OXi# 55 BZL# 55 cyclin dependent kinase inhibitor 55 diagnostic biomarker 55 Alkaline Phosphatase 55 Symadex 55 glioblastoma cells 55 Archexin 55 DOS# 55 VEGFR 55 docetaxel Taxotere ® 55 XmAb ® 55 vWF 55 ischemic tissues 55 potent anticancer 55 polysaccharide polymer 55 Nanobodies 55 molecular abnormalities 55 Factor VEGF 55 product platforms AZX# 55 adenoviral vector 55 #HT#A 55 mitogen activated ERK kinase 55 optical biosensors 55 GLPG# 55 Endologix Powerlink System 55 virotherapy 55 anti CD3 antibody 55 Tissue Matrix 55 aptamer 55 phosphoprotein 55 vemurafenib 55 CA4P 55 Resurgex Plus R 55 KNS # 55 HyperAcute 55 Phase Ib study 55 polymerase inhibitors 55 epothilones 55 milatuzumab 55 annexin V 55 thymidylate synthase TS 55 Monoclonal antibody 55 PI3 kinase 55 phosphatidylserine PS targeting 55 isotype 55 nanomolar 55 dimebon latrepirdine 55 transfection reagent 55 shRNA 55 Additional BiTE antibodies 55 cathepsins 55 Curaxin 55 cancer immunotherapies 55 HGF 55 XmAb 55 nitride GaN 55 cellular cytotoxicity 55 HCV replicon 55 #ME# 55 ActA 55 antisense compounds 55 anticancer therapy 55 ErbB3 HER3 55 adenosine receptor 55 Alferon N 55 VEGF receptor inhibitor 55 SGLT2 55 Aganocide 55 Company proprietary Biochronomer 55 ArQule Kinase Inhibitor Platform 55 Golimumab 55 trabectedin 55 Pradefovir 55 clusterin 55 Monoclonal antibodies 55 NPM1 55 multitargeted 55 QPCR 55 Affibody 55 Fc gamma receptors 55 HAAH 55 dSLIM 55 cilengitide 55 EndoTAG TM 55 Morpholino 55 inflammatory cytokine 55 MelaFind R 55 NEUGENE antisense 55 virosomes 55 HTRF R 55 K RAS 55 pharmacologic agents 55 E2F 55 preclinical efficacy 55 multivalent vaccine 55 primary GeckoSavants 55 plasma kallikrein 55 IgG antibody 55 Methylnaltrexone 55 miR #a [002] 55 cytochrome P# inhibition 55 IL#B 55 AvalonRx R 55 proteinase 55 YONDELIS 55 ANG# 55 CD# antigen 55 miR #b [002] 55 triphendiol 55 personalized immunotherapy 55 nucleoside analogues 55 MAXY G# 55 LEAPS TM 55 RNA antagonist 55 RNAi mediated 55 synthetic siRNA 55 BEMA TM LA 55 predictive biomarkers 55 qNPA 55 Nuclear Pharm Assist 55 IFN alpha 55 MAPK pathway 55 Tesmilifene 55 molecular imaging radiopharmaceuticals 55 novel anticancer 55 ribonuclease 55 synthetic retinoid 55 ganciclovir 55 tumorigenicity 55 systemic RNA interference 55 PDGF receptor 55 HTRF 55 JAK2 inhibitors 55 Hemopurifier TM 55 receptor CXCR4 55 IL 1ß 55 immune modulation 55 immunotherapeutic agent 55 pertussis toxin 55 Biosensor System 54 T DM1 54 antiangiogenic 54 naturally occurring molecule 54 RhuDex ® 54 synthetic siRNAs 54 Zybrestat 54 mesothelin 54 immunomodulators 54 neovascular diseases 54 infill submarkets 54 IAP inhibitors 54 LSI #P 54 oral JAK1 54 pDCs 54 generation antisense 54 MAbs 54 Genentech Herceptin 54 Fodosine 54 small molecule thrombopoietin 54 LNPs 54 vivo validation 54 immunogens 54 specific dataplane 54 Trandolapril 54 delafloxacin 54 obatoclax 54 epothilone 54 Biolimus A9 54 HepDirect 54 DermaPrep 54 predictive biomarker 54 NB S# strontium malonate 54 siRNA sequences 54 novel immunotherapeutic 54 deacetylase inhibitors 54 KB# [004] 54 Davanat 54 NeuroTrans TM 54 INGN 54 BRAF mutation 54 CCR1 54 synthetic cannabinoid library 54 Elesclomol 54 RNA amplification 54 polyclonal 54 protein CETP 54 viral proteins 54 Safinamide 54 radiation sensitizer 54 TSLP 54 RainStorm 54 receptor ligand 54 short hairpin RNAs 54 splice variants 54 ALTTO 54 gp# [002] 54 Panzem 54 TG# [001] 54 Exherin TM 54 OvaRex R 54 metabolite identification 54 p# antigen 54 VEGF inhibitors 54 kinase inhibition 54 synthetic peptides 54 interferon IFN 54 EGFRvIII 54 active cellular immunotherapy 54 Tem PCR 54 engineered anticoagulant 54 Nimotuzumab 54 TLR8 54 GW# [003] 54 osteoclast 54 Hsp# inhibitors 54 hematological indications 54 anti angiogenic 54 Crucell PER.C6 ® 54 solithromycin 54 situ hybridization 54 reverse transcriptase polymerase chain 54 Investigational eFlow 54 antisense drugs 54 Oncotype DX colon cancer 54 ON #.Na 54 Mutational 54 EKC Cide 54 Vaxfectin TM adjuvant 54 imetelstat 54 monoclonal 54 siRNA therapeutics